Green Cross Medical Science Corporation (KOSDAQ:142280)

Market Cap	80.32B
Revenue (ttm)	103.85B
Net Income (ttm)	3.58B
Shares Out	21.71M
EPS (ttm)	41.00
PE Ratio	90.24
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	117,409
Average Volume	409,268
Open	3,945.00
Previous Close	3,935.00
Day's Range	3,850.00 - 3,990.00
52-Week Range	3,090.00 - 6,950.00
Beta	0.46
RSI	40.21
Earnings Date	Mar 17, 2025

About KOSDAQ:142280

Green Cross Medical Science Corporation manufactures and sells diagnostic reagents and medical devices in South Korea and internationally. The company offers immunology diagnostic reagents. It also provides COVID-19 kit; blood glucose monitoring system; HbA1c test machine; and Gcare LIPID and LIPID printer. Green Cross Medical Science Corporation was founded in 1972 and is headquartered in Yongin-Si, South Korea.

• Industry: In Vitro and In Vivo Diagnostic Substances
• Founded: 1972
• Employees: 128
• Stock Exchange: KOSDAQ
• Ticker Symbol: 142280

Financial Performance

In 2024, KOSDAQ:142280's revenue was 103.85 billion, an increase of 10.47% compared to the previous year's 94.01 billion. Earnings were 3.58 billion, an increase of 99.25%.